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Several studies have identiﬁed a relationship between myelodysplastic syndrome and Behçetʼs disease 
(BD),  especially intestinal BD,  and trisomy 8 appears to play an important role in these disorders.  
Despite this,  only few case reports or series have been reported in gastroenterology,  meaning that 
endoscopic ﬁndings and characteristics of intestinal BD have not been clariﬁed yet.  In this report,  we 
describe three cases of intestinal BD associated with myelodysplastic syndrome and trisomy 8,  and 
discuss the clinical features and problems of these disorders from a gastroenterology perspective.
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ehçetʼs disease (BD) is a chronic multisystem 
inﬂammatory disease ﬁrst deﬁned in the 1930s 
by Hulusi Behçet,  and it is characterized by 4 clinical 
features: recurrent oral ulcers,  genital ulcers,  uveitis,  
and skin lesions [1].  Many other systems can be 
involved,  such as the gastrointestinal tract,  central 
nervous system,  cardiovascular system,  and the mus-
culoskeletal system (in the form of arthritic joints).
　 Myelodysplastic syndrome (MDS) is a clonal hema-
tologic disorder that easily converts to acute leukemia 
[2].  It is characterized by stem cell disorders,  multi-
lineage dysplasia,  and pancytopenia due to ineﬀective 
hematopoiesis.  Although BD and MDS are two diﬀer-
ent disease entities,  several studies have identiﬁed a 
relationship between them,  especially in the context of 
intestinal BD.  Previous reports have also revealed 
that the chromosomal disorder trisomy 8 seems to play 
an important role in these disorders [3-11] As most 
of the BD and MDS cases or case series were reported 
by hematologists or rheumatologists,  the clinical 
characteristics and endoscopic features of gastroin-
testinal involvement have not been adequately described 
from a gastroenterological perspective [5,  6].
　 Here we describe three cases of intestinal BD 
associated with MDS and trisomy 8.  We illustrate the 
features of intestinal lesions,  including those of the 
small intestines,  as examined by colonoscopy and 
double-balloon endoscopy (DBE).  We also discuss the 
clinical features and speciﬁc problems associated with 
these cases from the perspective of gastroenterologists.
Case Reports
　 Case 1. An 81-year-old Japanese man was 
referred to our hospital with frequent melena from 
multiple ulcers of the terminal ileum.  DBE via the 
anal approach was performed,  and multiple simple 
B
Acta Med.  Okayama,  2015
Vol.  69,  No.  6,  pp.  365ﾝ369
CopyrightⒸ 2015 by Okayama University Medical School.
Case Report http ://escholarship.lib.okayama-u.ac.jp/amo/
Received April 17, 2015 ; accepted July 21, 2015.
＊Corresponding author. Phone : ＋81ﾝ86ﾝ235ﾝ7219; Fax : ＋81ﾝ86ﾝ225ﾝ5991
E-mail : skawano@mpd.biglobe.ne.jp (S. Kawano)
Conﬂict of Interest Disclosures: No potential conﬂict of interest relevant 
to this article was reported.
ulcers with typical large oval shapes were detected in 
the deep ileum and terminal ileum (Fig.  1A).  The 
histopathological examination of these ulcers showed 
nonspeciﬁc inﬂammation.  He had relapsing oral aph-
thae,  but no genital aphthae,  or cutaneous,  ophthal-
mologic,  or neurologic lesions.  HLA-B51 was exam-
ined,  but negative.  According to the above results,  
the patient was suspected of having intestinal BD.  
Several days after the DBE,  massive bleeding occurred 
in the patientʼs terminal ileum,  and hemostasis was 
achieved endoscopically.  Treatment with per-oral 
steroids and continuous intravenous cyclosporin A 
infusion soon led to complete resolution of the melena.
　 Four weeks later,  DBE revealed that the multiple 
ulcers had healed with minor scarring on the walls 
(Fig.  1B).  However,  moderate pancytopenia pro-
gressed throughout the clinical course.  In particular,  
anemia continued despite complete resolution of the 
intestinal bleeding.  A bone marrow examination 
revealed profound hypocellularity and the presence of 
trisomy 8.  The patient was diagnosed with refractory 
anemia with ring sideroblasts (RARS).  Immuno-
suppressive therapy was continued but the patient died 
from septic shock due to a urinary infection 7 months 
after being referred to our hospital.
　 Case 2. A 45-year-old Japanese man,  who had 
been diagnosed with BD 5 years earlier based on the 
presence of aphthous oral ulcers and genital lesions 
with HLA-B51 positivity,  was admitted to our hospi-
tal for abdominal pain and diarrhea.  A colonoscopy 
was performed and revealed punched-out lesions 
around the ileocecal bulb that had created a ﬁstula 
into the ileum (Fig.  2A).  The patient was found to be 
pancytopenic and was simultaneously diagnosed with 
refractory anemia (RA) and trisomy 8.  The International 
Prognostic Scoring System (IPSS) score was int-1.
　 Six months later,  the patient developed excessive 
bleeding and localized peritonitis that could not be 
controlled by conservative therapy; therefore,  ileoce-
cal resection with ileostomy was performed (Fig.  2B).  
However,  multiple ulcers compatible with intestinal 
BD recurred at the stoma site and in the residual 
ileum (Fig.  2C).  He was considered to require reso-
lution of both BD and MDS and a change in the 
behavior of the disease through resetting of the entire 
immune response by transplantation.  Therefore,  
peripheral blood stem cell transplantation (PBSCT) 
was performed.  Nevertheless,  the patient died of 
septic shock due to enteritis after 3 months.
　 Case 3. Two years prior to his referral to our 
hospital,  the 64-year-old Japanese male patient had 
already been diagnosed with MDS (RA,  IPSS int-1) 
with trisomy 8.  Chronic anemia and thrombocytopenia 
continued,  and immunosuppressive therapy was not 
eﬀective.  He was then referred to our hospital to 
undergo cord blood transplantation (CBT).  Soon after 
admission,  he developed frequent episodes of massive 
gastrointestinal (GI) bleeding that required an emer-
gency colonoscopy,  which revealed multiple simple 
ulcers－consistent with intestinal BD symptoms－in 
the ascending colon and terminal ileum (Fig.  3A).  
Several days later,  multiple bleeding ulcers were 
revealed by DBE (Fig.  3B),  but we could not endo-
scopically control the GI bleeding.  Finally,  the 
angiographic examination revealed extravasation,  and 
the bleeding was stopped by transcatheter emboliza-
tion.  Although the patient had undergone CBT,  he 
later died of septic shock due to pneumonia.
Discussion
　 We have presented the cases of 3 patients with 
intestinal BD associated with MDS and trisomy 8.  
All 3 patients had intestinal lesions and exhibited 
severe bleeding that required hemostasis.
　 The reported frequency of intestinal ulcers in BD 
is 3-16ｵ [10].  However,  Ahn et al.  reported that 
the frequency of intestinal BD was signiﬁcantly higher 
in patients with BD with bone marrow failure com-
pared to those without bone marrow failure (61.5ｵ 
vs. 13.6ｵ) [3].  Handa et al.  reviewed the data of 64 
patients with BD and MDS,  and they observed high 
frequencies of intestinal lesions (66ｵ) and trisomy 8 
(80ｵ) but a low frequency of ocular lesions (13ｵ).  In 
particular,  the data demonstrated that intestinal 
lesions were characteristic ﬁndings in BD associated 
with trisomy 8 and bone marrow failure,  especially in 
MDS [12].
　 Several mechanisms have been demonstrated to 
explain the association between BD and MDS.  Tada 
et al.  indicated that trisomy 8 may lead to the devel-
opment of intestinal ulcers in patients with MDS 
because the presence of trisomy 8 facilitates the pro-
duction of inﬂammatory cytokines such as tumor 
necrosis factor-alpha (TNF-α),  interferon (IL)-6,  and 
IL-1β,  which enhance neutrophil function and is a 
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known risk factor for intestinal ulcers [4].
　 Interestingly,  most of these cases were in East 
Asia,  including Japan and Korea.  Kawabata et al.  
suggested the importance of the regional,  racial,  and 
environmental background of patients [7].  HLA-B51,  
one of the common allele types among Japanese,  has 
been implicated in the higher occurrence of BD in 
Japanese.  However,  among the present 3 patients,  
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Fig. 1　 Case 1,  an 81-year-old man. (A) DBE 
showed multiple simple ulcers in the deep and 
terminal ileum.  (B) Four weeks later,  the multiple 
ulcers had healed and become scars.
Fig. 2　 Case 2,  a 45-year-old man.  (A) 
Colonoscopy revealed punched-out lesions 
around the ileocecal bulb.  (B) Ileocecal 
resection with ileostomy revealed penetra-
tion between the ascending colon and ter-
minal ileum,  as well as multiple ulcers in 
the ileum.  (C) Multiple ulcers recurred at 
the stoma site and in the residual ileum.
only Case 2 had HLA-B51.  Together with the previ-
ously reported cases [4, 6, 7, 9, 11],  trisomy 8 seems 
to be a much more important risk factor for BD rather 
than HLA-B51 in patients with MDS with trisomy 8.
　 Lessons can be learned from our 3 patients regard-
ing the management of intestinal BD in patients with 
MDS and trisomy 8.  First,  all 3 patients had intesti-
nal lesions in the ileocecal region and deep in the small 
intestine.  The ileocecal region and the ascending colon 
are known to be representative sites of gastrointesti-
nal involvement in BD [11].  Small bowel involvement 
was recently detected in BD using capsule endoscopy 
and DBE [13].  We speculate that the small intestine 
is aﬀected in many patients with BD given that ent-
eroscopic examinations have been limited to only 
selected patients.  We suggest that an examination of 
the small intestine with balloon endoscopy or capsule 
endoscopy should be performed in patients with intesti-
nal BD,  particularly in those with MDS and trisomy 8.
　 In addition,  the onset of MDS and BD is not 
always simultaneous.  In our Case 1,  hematological 
abnormalities appeared several months after the intes-
tinal symptoms,  whereas BD had been diagnosed over 
5 years earlier in Case 2.  In Case 3,  MDS had been 
diagnosed 2 years earlier and the patient was only 
seen during referral to receive CBT.  Patients in 
whom the diagnosis of MDS precedes that of BD usu-
ally undergo a follow-up by a hematologist.  Indeed,  
most of the cases in the literature were reported by 
hematologists.  Gastroenterologists should therefore 
take into account the possibility of intestinal ulcers in 
patients with MDS and trisomy 8.
　 Case 2 was diagnosed with complete BD,  and deep 
ileocecal ulcers were recognized as typical lesions of 
intestinal BD that cause localized peritonitis.  However,  
after ileocecal resection,  the lesions in all 3 patients 
were revealed to be relatively superﬁcial and multiple 
in numbers.
　 There have been few reports of the characteristics 
of intestinal BD associated with MDS and trisomy 8.  
Hisamatsu et al.  noted that the endoscopic ﬁndings of 
these lesions were diﬀerent from those of typical 
intestinal BD (i.e.,  those with no association with 
MDS or trisomy 8),  and the ﬁndings showed giant,  
oval,  punched-out ulcers at the ileocecum [14].  We 
speculate that multiple superﬁcial ulcers are a charac-
teristic of intestinal BD associated with MDS and 
trisomy 8.  However,  further investigation is required 
to clarify the similarities and diﬀerences of intestinal 
BD lesions in patients with and without MDS and 
trisomy 8.
　 Lastly,  our 3 patients had poor prognoses.  In 
Japan,  the administration of 5-aminosalicylate,  corti-
costeroids,  and immunosuppressants is typically rec-
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Fig. 3　 Case 3,  a 64-year-old man.  (A) 
Colonoscopy revealed multiple simple ulcers in the 
ascending colon and terminal ileum.  (B) Multiple 
bleeding ulcers were revealed by DBE.
ommended as standard therapy for intestinal BD [15].  
Additionally,  eﬀective anti-TNFα monoclonal antibody 
therapy (inﬂiximab and adalimumab) has been devel-
oped [16].  Kimura et al.  recently reported the use-
fulness of adalimumab in the treatment of a case of 
intestinal BD with trisomy 8 MDS [17].  Whereas 
several reports suggested that inﬂiximab might not be 
eﬀective [5,  11].  We still think that the use of anti-
TNFα monoclonal antibody therapy is controversial,  
because diﬃcult-to-control infections could occur in 
association with MDS and trisomy 8 as described in 
our three cases.  Tanaka et al.  reported the eﬀective-
ness of azacitidine therapy [11],  but there was also 
insuﬃcient evidence.  There have also been a few case 
reports and systemic reviews of the successful treat-
ment of intestinal BD with trisomy 8 MDS by bone 
marrow transplantation [9,  18],  which,  we believe,  
is the best therapy at present,  particularly for 
younger patients.  However,  Soysal et al.  warned that 
potentially fatal adverse events and complications of 
bone marrow transplantation therapy must be taken 
into consideration [18].  Gastroenterologists should 
pay particular attention to any intestinal bleeding,  
making the evaluation of the entire gastrointestinal 
tract vital in such patients.
　 In conclusion,  we have described 3 cases of intes-
tinal BD associated with MDS and trisomy 8.  The 
diagnosis and treatment of such patients may be com-
plicated,  but we believe that an improved understand-
ing of the complex disease and collaborative eﬀorts by 
hematologists,  rheumatologists,  and gastroenterolo-
gists can lead to improved care and reduce adverse 
outcomes.
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